Superior efficacy of Lastacaft® versus Pataday in grass- and tree-allergic subjects Ackerman, Stacey L.1; Ciolino, Joseph B.2; Williams, Julia M.3; Hollander, David A.3
Presentation Number – Posterboard Number: 312 – C0126
Session Number: 113
Session Title: Allergic conjunctivitis / Corneal Immunology and Infection
Session Date/ Times: May 1, 2016 from 8:30 AM to 10:15 AM
Incidence and severity of itchy palate following conjunctival allergen challenge: Schoemmell, Emily1; Raval, Yesha1; Welch, Donna L.1; Gomes, Paul J.1; Lane, Keith J.1
Presentation Number – Posterboard Number: 310 – C0124
Session Number: 113
Session Title: Allergic conjunctivitis / Corneal Immunology and Infection
Session Date/ Times: May 1, 2016 from 8:30 AM to 10:15 AM
Reducing nasal and ocular itching with a novel drug in the BioCube® allergy chamber Gomes, Paul J.1; Villafranca, J. Ernest2; Viirre, Erik2; Lasser, Elliott2; Abelson, Mark B.1
Presentation Number – Posterboard Number: 305 – C0119
Session Number: 113
Session Title: Allergic conjunctivitis / Corneal Immunology and Infection
Session Date/ Times: May 1, 2016 from 8:30 AM to 10:15 AM
Phase 3 Study on the Efficacy, Safety and Tolerability of Isunakinra (EBI-005) in Subjects with Moderate to Severe Allergic Conjunctivitis Michael H. Goldstein1,2 , Leontia Burke2 , Karen L. Tubridy2 , Karen Dewar2 , Paul J. Gomes3
Presentation Number – 307 – C0121 Posterboard Number: C0121
Session Number: 113
Session Title: Allergic conjunctivitis / Corneal Immunology and Infection
Session Date/ Times: May 1, 2016 from 8:30 AM to 10:15 AM
May 2, 2016 8:30 AM – 10:15 AM
Diurnal Blink Tracking of Symptomatic Contact Lens Wearers Angjeli, Endri1; Rodriguez, John D.1; Lane, Keith J.1; Ousler, George W.2; Watson, Michael2
Presentation Number – Posterboard Number: 1486 – A0166
Session Number: 217
Session Title: Contact Lenses
Session Date/ Times: May 2, 2016 from 8:30 AM to 10:15 AM
May 3, 2016 8:30 AM – 10:15 AM
Ocular Surface Thermal Imaging in Normal and Dry Eye Subjects Watson, Michael1; Lane, Keith J.2; Angjeli, Endri2; Corcoran, Peter2; Rodriguez, John D.2; Ousler, George W.1
Presentation Number – Posterboard Number: 2858 – A0067
Session Number: 310
Session Title: Dry Eye II
Session Date/ Times: May 3, 2016 from 8:30 AM to 10:15 AM
Ocular Surface Thermal Imaging Pre- and Post-CAESM Sundstrom, Christian1; Lane, Keith J.1; Angjeli, Endri1; Corcoran, Peter1; Ousler, George W.2
Posterboard Number: 2851-A0060
Session Number: 310
Session Title: Dry Eye II
Session Date/Times: May 3, 2016 from 8:30 AM to 10:15 AM
Objective Measurement of Eyelash Parameters and their Relation to Dry Eye Disease Rodriguez, John1;Corcoran, Peter1; Angjeli, Endri1; Sundstrom, Christian1; Ousler, George W.2
Presentation Number – Posterboard Number: 2837 – A0046
Session Number: 310
Session Title: Dry Eye II
Session Date/ Times: May 3, 2016 from 8:30 AM to 10:15 AM
The effect of TRPM8-agonist menthol eyedrops on tear meniscus area and height
Corcoran, Peter2; Angjeli, Endri2; Lane, Keith J.2; Ousler, George W.3; Watson, Michael3; Abelson, Mark B.1
Presentation Number – Posterboard Number: 2873 – A0082
Session Number: 310
Session Title: Dry Eye II
Session Date/ Times: May 3, 2016 from 8:30 AM to 10:15 AM
May 3, 2016 3:45 PM to 5:30 PM
Treatment of Chronic Allergic Conjunctivitis with Sustained Release Dexamethasone Using a Modified Conjunctival Allergen Challenge (Ora-CAC®) Model : D. Mulani, E. McLaurin, MD, C. Repke, MD, M. Sato, MD, P. Gomes, M. Bassett, C. Blizzard, A. Driscoll, A. Sawhney
Presentation Number – Posterboard Number: 4021-B0199
Session Title: Drug Delivery
Session Date / Times: Tue, May 03 from 3:45pm – 5:30pm
May 4, 2016 3:45 PM to 5:30 PM
Evaluation of the effects of SkQ1 in Ora’s rabbit anterior chamber paracentesis model Violette, Kortni 1; Schillo, Christopher1; Whitlock, Andy1; Petrov, Anton2
Presentation Number – Posterboard Number: 5414 – B0154
Session Number: 475
Session Title: Inflammation
Session Date/ Times: May 4, 2016 from 3:45 PM to 5:30 PM
Ora, Inc websites use cookies. By continuing to browse the site you are agreeing to our use of cookies.
For more details about cookies and their use, please see our Privacy Policy.